Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sight Sciences (SGHT) Equity Average (2021 - 2025)

Historic Equity Average for Sight Sciences (SGHT) over the last 5 years, with Q3 2025 value amounting to $67.2 million.

  • Sight Sciences' Equity Average fell 3168.6% to $67.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.2 million, marking a year-over-year decrease of 3168.6%. This contributed to the annual value of $103.9 million for FY2024, which is 2588.49% down from last year.
  • Sight Sciences' Equity Average amounted to $67.2 million in Q3 2025, which was down 3168.6% from $73.8 million recorded in Q2 2025.
  • Sight Sciences' Equity Average's 5-year high stood at $239.0 million during Q4 2021, with a 5-year trough of $64.3 million in Q3 2021.
  • For the 5-year period, Sight Sciences' Equity Average averaged around $132.9 million, with its median value being $123.6 million (2023).
  • Its Equity Average has fluctuated over the past 5 years, first surged by 18339.93% in 2022, then crashed by 3168.6% in 2025.
  • Over the past 5 years, Sight Sciences' Equity Average (Quarter) stood at $239.0 million in 2021, then tumbled by 30.34% to $166.5 million in 2022, then dropped by 25.74% to $123.6 million in 2023, then fell by 26.21% to $91.2 million in 2024, then decreased by 26.4% to $67.2 million in 2025.
  • Its last three reported values are $67.2 million in Q3 2025, $73.8 million for Q2 2025, and $82.6 million during Q1 2025.